224 related articles for article (PubMed ID: 31488697)
21. Molecular beacon based real-time PCR p1 gene genotyping, macrolide resistance mutation detection and clinical characteristics analysis of Mycoplasma pneumoniae infections in children.
Li L; Ma J; Guo P; Song X; Li M; Yu Z; Yu Z; Cheng P; Sun H; Zhang W
BMC Infect Dis; 2022 Sep; 22(1):724. PubMed ID: 36068499
[TBL] [Abstract][Full Text] [Related]
22. Epidemiology and mechanism of drug resistance of Mycoplasma pneumoniae in Beijing, China: A multicenter study.
Guo DX; Hu WJ; Wei R; Wang H; Xu BP; Zhou W; Ma SJ; Huang H; Qin XG; Jiang Y; Dong XP; Fu XY; Shi DW; Wang LY; Shen AD; Xin DL
Bosn J Basic Med Sci; 2019 Aug; 19(3):288-296. PubMed ID: 30878034
[TBL] [Abstract][Full Text] [Related]
23. Allele-specific real-time PCR testing for minor macrolide-resistant Mycoplasma Pneumoniae.
Guo D; Hu W; Xu B; Li J; Li D; Li S; Wu Z; Wei R; Tian X; Shen K; Xin D
BMC Infect Dis; 2019 Jul; 19(1):616. PubMed ID: 31299916
[TBL] [Abstract][Full Text] [Related]
24. Emergence of macrolide-resistant Mycoplasma pneumoniae with a 23S rRNA gene mutation.
Morozumi M; Hasegawa K; Kobayashi R; Inoue N; Iwata S; Kuroki H; Kawamura N; Nakayama E; Tajima T; Shimizu K; Ubukata K
Antimicrob Agents Chemother; 2005 Jun; 49(6):2302-6. PubMed ID: 15917525
[TBL] [Abstract][Full Text] [Related]
25. Increased macrolide resistance of Mycoplasma pneumoniae in France directly detected in clinical specimens by real-time PCR and melting curve analysis.
Peuchant O; Ménard A; Renaudin H; Morozumi M; Ubukata K; Bébéar CM; Pereyre S
J Antimicrob Chemother; 2009 Jul; 64(1):52-8. PubMed ID: 19429926
[TBL] [Abstract][Full Text] [Related]
26. Mycoplasma pneumoniae 23S rRNA A2063G mutation does not influence chest radiography features in children with pneumonia.
Deng H; Rui J; Zhao D; Liu F
J Int Med Res; 2018 Jan; 46(1):150-157. PubMed ID: 28760082
[TBL] [Abstract][Full Text] [Related]
27. Low Incidence of Macrolide-Resistant Mycoplasma pneumoniae between April 2016 and March 2017 in Akita Prefecture, Japan.
Suzuki S; Konno T; Shibata C; Saito H
Jpn J Infect Dis; 2018 Nov; 71(6):477-478. PubMed ID: 30175736
[No Abstract] [Full Text] [Related]
28. Development of macrolide resistance in Mycoplasma pneumoniae-infected Swedish patients treated with macrolides.
Nilsson AC; Jensen JS; Björkman P; Persson K
Scand J Infect Dis; 2014 Apr; 46(4):315-9. PubMed ID: 24447251
[TBL] [Abstract][Full Text] [Related]
29. More complications occur in macrolide-resistant than in macrolide-sensitive Mycoplasma pneumoniae pneumonia.
Zhou Y; Zhang Y; Sheng Y; Zhang L; Shen Z; Chen Z
Antimicrob Agents Chemother; 2014; 58(2):1034-8. PubMed ID: 24277047
[TBL] [Abstract][Full Text] [Related]
30. Novel mechanisms of macrolide resistance revealed by
Wang N; Xu X; Xiao L; Liu Y
Front Cell Infect Microbiol; 2023; 13():1186017. PubMed ID: 37284499
[No Abstract] [Full Text] [Related]
31. Epidemiology of macrolide-resistant Mycoplasma pneumoniae by age distribution in Japan.
Kawakami N; Namkoong H; Saito F; Ishizaki M; Yamazaki M; Mitamura K
J Infect Chemother; 2021 Jan; 27(1):45-48. PubMed ID: 32868199
[TBL] [Abstract][Full Text] [Related]
32. Multiple-locus variable-number tandem-repeat analysis (MLVA) of macrolide-susceptible and -resistant Mycoplasma pneumoniae in children in Taiwan.
Lu CY; Yen TY; Chang LY; Liau YJ; Liu HH; Huang LM
J Formos Med Assoc; 2020 Oct; 119(10):1539-1545. PubMed ID: 31924377
[TBL] [Abstract][Full Text] [Related]
33. Genetic diversity and macrolide resistance of Mycoplasma pneumoniae isolates from two consecutive epidemics in Slovenia.
Kogoj R; Praprotnik M; Mrvič T; Korva M; Keše D
Eur J Clin Microbiol Infect Dis; 2018 Jan; 37(1):99-107. PubMed ID: 28948376
[TBL] [Abstract][Full Text] [Related]
34. Community-acquired macrolide-resistant Mycoplasma pneumoniae pneumonia in patients more than 18 years of age.
Miyashita N; Maruyama T; Kobayashi T; Kobayashi H; Taguchi O; Kawai Y; Yamaguchi T; Ouchi K; Oka M
J Infect Chemother; 2011 Feb; 17(1):114-8. PubMed ID: 20676912
[TBL] [Abstract][Full Text] [Related]
35. Characterization of macrolide resistance in Mycoplasma pneumoniae isolated from children in Shanghai, China.
Liu Y; Ye X; Zhang H; Xu X; Li W; Zhu D; Wang M
Diagn Microbiol Infect Dis; 2010 Aug; 67(4):355-8. PubMed ID: 20638604
[TBL] [Abstract][Full Text] [Related]
36. Molecular features and antimicrobial susceptibility of Mycoplasma pneumoniae isolates from paediatric inpatients in Weihai, China: Characteristics of M. pneumoniae In Weihai.
Guo Z; Liu L; Gong J; Han N; He L; Wang W; Meng F; Xia X; Zhang J; Zhao F
J Glob Antimicrob Resist; 2022 Mar; 28():180-184. PubMed ID: 35017067
[TBL] [Abstract][Full Text] [Related]
37. Novel Variant and Known Mutation in 23S rRNA Gene of Mycoplasma pneumoniae, Northern Vietnam, 2023.
Nguyen DD; Ho NT; Dover LG; Vo AHM; Ly HTT; Doan PM; Nguyen HT; Luu NTT; Pham AN; Tran HTT
Emerg Infect Dis; 2024 May; 30(5):1034-1036. PubMed ID: 38573165
[TBL] [Abstract][Full Text] [Related]
38. Overview of antimicrobial options for Mycoplasma pneumoniae pneumonia: focus on macrolide resistance.
Cao B; Qu JX; Yin YD; Eldere JV
Clin Respir J; 2017 Jul; 11(4):419-429. PubMed ID: 26365811
[TBL] [Abstract][Full Text] [Related]
39. Nasopharyngeal carriage and macrolide resistance in Indigenous children with bronchiectasis randomized to long-term azithromycin or placebo.
Hare KM; Grimwood K; Chang AB; Chatfield MD; Valery PC; Leach AJ; Smith-Vaughan HC; Morris PS; Byrnes CA; Torzillo PJ; Cheng AC
Eur J Clin Microbiol Infect Dis; 2015 Nov; 34(11):2275-85. PubMed ID: 26363637
[TBL] [Abstract][Full Text] [Related]
40. Development of macrolide resistance-associated mutations after macrolide treatment in children infected with Mycoplasma pneumoniae.
Suzuki Y; Shimotai Y; Itagaki T; Seto J; Ikeda T; Yahagi K; Mizuta K; Hongo S; Matsuzaki Y
J Med Microbiol; 2017 Nov; 66(11):1531-1538. PubMed ID: 28984229
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
